WI
PFE icon

WHV Investments’s Pfizer PFE Stock Holding History

WHV Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-72,032
Closed -$2.09M – 185
2013
Q4 		$2.09M Sell
72,032
-171,916
-70% -$5M 0.02% 149
2013
Q3 		$6.65M Sell
243,948
-30,583
-11% -$832K 0.07% 134
2013
Q2 		$7.3M Buy
+274,531
New +$7.59M 0.08% 128

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

WHV Investments's PFE Position: Q1 2014 in Review

WHV Investments sold out of Pfizer (PFE) in Q1 2014, closing a stake of 72,032 shares — an estimated $2.09M sold.

WHV Investments first reported a position in PFE in Q2 2013 and held it in 3 quarters. The position peaked at $7.3M in Q2 2013. 1,780 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

  • WHV Investments reported no remaining Pfizer position as of Q1 2014 after selling out during the quarter.
  • WHV Investments sold 72,032 Pfizer shares in Q1 2014, an estimated $2.09M.
  • WHV Investments first reported a position in Pfizer in Q2 2013 and held it in 3 quarters.
  • WHV Investments's Pfizer position peaked at $7.3M in Q2 2013.
  • 1,780 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on WHV Investments's 13F filing for Q1 2014, filed 13 May 2014.